Relationship Between Left Ventricular Ejection Fraction and ICD‐10 Codes Among Patients Hospitalized With Heart Failure
While there was relatively good concordance between LVEF and the ICD-10 code-defined HF type for systolic HF, diastolic HF, and systolic and diastolic HF, these codes represent a small subset (~10%) of total HF hospitalizations.
Authors
- Deanna Rider
- Phil Tseng (ORCID: https://orcid.org/0009-0000-3737-344X)
- Mario Enrico Canonico (ORCID: https://orcid.org/0000-0001-8452-7464)
- Slaven Sikirica
- Joshua D. Remick
- Judith A. Hsia (ORCID: https://orcid.org/0000-0002-3413-7836)
- Ty J. Gluckman (ORCID: https://orcid.org/0000-0002-7187-6822)
- Craig Granowitz (ORCID: https://orcid.org/0000-0003-1533-3679)
- Marc P. Bonaca (ORCID: https://orcid.org/0000-0002-9860-3584)
- Shih‐Ting Chiu
- James O. Mudd
- Amy Carroll
Institutions
- Providence Sacred Heart Medical Center (US)
- University of Arizona (US)
- Providence College (US)
- University of Colorado Health (US)
- Lexicon Pharmaceuticals (United States) (US)
- Sisters of Providence Health System (US)
- Research Network (United States) (US)
Publication Details
- Journal
- Clinical Cardiology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/clc.70055
- Citations
- 1
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- American Heart Association
- Amgen
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- Medpace
- Osiris Therapeutics
- Novartis Pharmaceuticals Corporation
- CSL Behring
- Regeneron Pharmaceuticals
- Agios Pharmaceuticals
- Janssen Scientific Affairs
- Northwell Health
- ARCA Biopharma
- Novo Nordisk
- Esperion Therapeutics